Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Online resources offer a wealth of information for investment research. Learn how to leverage these tools to improve your investment approach.
21,367 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A chilling real-world scam shows how urgency and fear can drive seniors to hand over valuables. This guide breaks dow...
Wall Street is split on two big AI chips players: Intel and Marvell. One stock is riding optimism about data-center d...
A new moisture-absorbing paint-and-primer system backed by large homebuilders is entering the market, promising to re...
As the world ages, demand for life-saving medical devices grows. This article breaks down three pragmatic reasons why...
Energy stocks are rallying as demand rebounds and cash flow improves. This piece spotlights the best energy stocks to...
A letter allegedly from Sam Bankman-Fried is under intense scrutiny as prosecutors question its authenticity. Amid fa...
As the AI infrastructure boom intensifies, communities push back against giant data centers. Kevin O’Leary’s Stratos ...
DEI labels face political heat, but industry leaders argue the underlying work remains essential for growth and talen...
A common retirement move—selling a primary home with a large capital gain—can trigger higher Medicare premiums two ye...
A tech founder explains why he dismissed roughly 80% of his team after AI resistance and what it means for workers an...
A prominent billionaire hedge fund manager argues AI is becoming a daily utility and could spawn the first $10 trilli...